Aldawaa Medical Services Co. (4163.SR) Financials
4163.SR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2022-06-30 | 4.8 billion | 3.7 billion |
| 2022-03-31 | 4.3 billion | 3.3 billion |
| 2021-12-31 | 4.0 billion | 3.0 billion |
| 2021-09-30 | ? | ? |
4163.SR Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2022-06-30 | 18.9 million | ? |
| 2022-03-31 | 80.1 million | ? |
| 2021-12-31 | ? | ? |
| 2021-09-30 | ? | ? |
4163.SR Net Income
| Date | Net Income |
|---|---|
| 2022-06-30 | 80.7 million |
| 2022-03-31 | 87.1 million |
| 2021-12-31 | 53.7 million |
| 2021-09-30 | 53.7 million |
4163.SR Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2022-06-30 | 55.7 million | 1.6 billion | 1.8 billion |
| 2022-03-31 | 47.6 million | 834.5 million | 1.1 billion |
| 2021-12-31 | 46.3 million | 812.3 million | - |
| 2021-09-30 | - | - | - |
4163.SR Shares Outstanding
4163.SR Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2022-06-30 | 91.9 million | - | 416.2 million | - |
| 2022-03-31 | 76.0 million | - | 423.5 million | - |
| 2021-12-31 | 101.9 million | - | 1.6 billion | - |
| 2021-09-30 | 101.9 million | - | - | - |
4163.SR Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2022-06-30 | 1.3 billion | 803.4 million |
| 2022-03-31 | 1.3 billion | 800.6 million |
| 2021-12-31 | 5.0 billion | 3.1 billion |
| 2021-09-30 | - | - |
4163.SR
Price: SAR94
Dividend Yield: 0.03%
Forward Dividend Yield: 2.66%
Payout Ratio: 64.60%
Dividend Per Share: 2.50 SAR
Earnings Per Share: 3.87 SAR
P/E Ratio: 29.22
Exchange: SAU
Sector: Healthcare
Industry: Pharmaceutical Retailers
Market Capitalization: 8.0 billion
Average Dividend Frequency: 3
Years Paying Dividends: 3